Remedy makes a lot of games. There’s CrossfireX, the somewhat outdated first-person shooter, a control multiplayer spin-off title codenamed “Condor,” the recently announced Alan Wake 2, a full Control sequel to be released with 505 Games, and finally Vanguard, a free co-op shooter published by both Remedy and Tencent.
Remedy announced today that Tencent has signed the license and distribution of Vanguard in “select Asian markets”. Tencent will also co-fund the game, split the revenue after development costs, and also create a mobile version of Vanguard that will be developed and released separately.
“We are excited about this long-term partnership with Tencent and can confidently say that it is an excellent fit in support of Vanguard’s ambitious plans,” said Tero Virtala, CEO of Remedy, in one Explanation. “Vanguard is a global opportunity and Tencent can support Remedy internationally and run its business in Asia and the wireless markets.”
In the same press release, Remedy revealed new details about the mysterious Vanguard. The game will be a “free, cooperative PvE shooter that combines Remedy’s narrative know-how and action gameplay into an immersive multiplayer experience.” It is created in Unreal Engine for PC and consoles and has a “typical Remedy Triple-A gaming budget”.
Vanguard is currently in the “proof-of-concept” phase, so don’t expect any closed betas anytime soon.
Tencent is one of the largest game publishers in the world, with two mobile games (PUBG and Honor of Kings) grossing over $ 1 billion this year alone. It recently acquired Back 4 Blood developer Turtle Rock Studios and built many other studios. Tencent currently owns 4% of Remedy.
Though not mentioned in the release, Tencent is perhaps best known for partnering with other companies to bring games to mainland China. However, Tencent recently came into conflict with Chinese regulators and has been suspended for three weeks over approving new apps. Combined with Steam’s temporary blackout in China, there is no guarantee that Vanguard will be seen in the Chinese market.
Continue reading
About the author
